author-photo

Steven M. Grauer

Princeton University

16

Papers

864

Citations

Citation Trend

Filter By

Papers (12) Sort By

Journal Conference Others

WS-50030 [7-{4-[3-(1H-inden-3-yl)propyl]piperazin-1-yl}-1,3-benzoxazol-2(3H)-one]: A Novel Dopamine D2 Receptor Partial Agonist/Serotonin Reuptake Inhibitor with Preclinical Antipsychotic-Like and Antidepressant-Like Activity

2010 Journal of Pharmacology and Experimental Therapeutics
Show All
- Source
- Cite
- Save
Citations (11)
Phosphodiesterase 11A in brain is enriched in ventral hippocampus and deletion causes psychiatric disease-related phenotypes

2010 Proceedings of the National Academy of Sciences of the United States of America
Show All
- Source
- Cite
- Save
Citations (56)
Receptor and behavioral pharmacology of WAY-267464, a non-peptide oxytocin receptor agonist.

2010 Neuropharmacology
Show All
- Source
- Cite
- Save
Citations (129)
The synthesis and biological evaluation of quinolyl-piperazinyl piperidines as potent serotonin 5-HT1A antagonists.

2010 Journal of Medicinal Chemistry
Show All
- Source
- Cite
- Save
Citations (13)
Old and New Pharmacology: Positive Allosteric Modulation of the α7 Nicotinic Acetylcholine Receptor by the 5-Hydroxytryptamine2B/C Receptor Antagonist SB-206553 (3,5-Dihydro-5-methyl-N-3-pyridinylbenzo[1,2-b:4,5-b′]di pyrrole-1(2H)-carboxamide)

2009 Journal of Pharmacology and Experimental Therapeutics
Show All
- Source
- Cite
- Save
Citations (61)
The orphan GPCR, GPR88, modulates function of the striatal dopamine system: a possible therapeutic target for psychiatric disorders?

2009 Molecular and Cellular Neuroscience
Show All
- Source
- Cite
- Save
Citations (65)
Procognitive and Neuroprotective Activity of a Novel α7 Nicotinic Acetylcholine Receptor Agonist for Treatment of Neurodegenerative and Cognitive Disorders

2009 Journal of Pharmacology and Experimental Therapeutics
Show All
- Source
- Cite
- Save
Citations (94)
Correlating Efficacy in Rodent Cognition Models with in Vivo 5-Hydroxytryptamine1A Receptor Occupancy by a Novel Antagonist, (R)-N-(2-Methyl-(4-indolyl-1-piperazinyl)ethyl)-N-(2-pyridinyl)-cyclohexane Carboxamide (WAY-101405)

2008 Journal of Pharmacology and Experimental Therapeutics
Show All
- Source
- Cite
- Save
Citations (29)
PRE-CLINICAL CHARACTERIZATION OF THE ALPHA-7 NICOTINIC RECEPTOR AGONIST SEN12333/WAY-317538

2008 Schizophrenia Research
Show All
- Source
- Cite
- Save
Citations (0)
P.3.d.019 Vabicaserin: effects of a novel 5-HT2C agonist on medial prefrontal cortex neurotransmission, cognition and sensorimotor gating

2007 European Neuropsychopharmacology
Show All
- Source
- Cite
- Save
Citations (4)